| 摘要: |
| 目的 探讨沙格列汀联合盐酸二甲双胍治疗糖尿病的临床分析疗效,对胰岛β细胞保护作用和糖化血红蛋白(HbA1c)的达标率分析。方法 将我院2018年6月至2021年6月137例糖尿病患者分组,按照简单随机数字表法分为对照组(n=68)和观察组(n=69),对照组采用盐酸二甲双胍治疗,观察组立足于对照组基础上采用沙格列汀治疗。评估两组糖尿病患者的临床疗效,比较患者的血清胰岛素(Ins)、C肽、餐后2 h血糖(PBG)、空腹血糖(FBG)、糖化血红蛋白、不良反应发生情况。结果 观察组总有效率为95.65%,高于对照组的83.82%(P<0.05);与治疗前相比,治疗后两组胰岛素、C肽水平均上升,且观察组高于对照组(P<0.05);与治疗前相比,治疗后两组餐后2 h血糖、空腹血糖、糖化血红蛋白水平均下降,且观察组低于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论 沙格列汀联合盐酸二甲双胍治疗糖尿病患者具有明显的临床疗效,可提高胰岛素、C肽水平,降低餐后2 h血糖、空腹血糖、糖化血红蛋白水平,对胰岛β细胞起到保护作用,患者出现不良反应的概率较少,用药较为安全可靠。 |
| 关键词: 沙格列汀 盐酸二甲双胍 糖尿病 胰岛β细胞 达标率 |
| DOI:10.13506/j.cnki.jpr.2022.09.011 |
| 基金项目: |
|
Publication Date:September 25, 2022
|
|
| Clinical efficacy of Shah Glenn Dean combined with metformin hydrochloride in the treatment of diabetes and analysis of the protective effect of islet β cells of and target rate of HbA1c |
| XIANG Xiaomei1,LYU Xiaofang2 |
| (1.Yantai Wanhua Hospital,Yantai 264000,China;2.Yantai Laiyang Central Hospital,Yantai 265200,China) |
| Abstract: |
| Objective To investigate the clinical efficacy of Shah Glenn Dean combined with metformin hydrochloride in the treatment of diabetes and analysis of the protective effect of islet β cells of and target rate of HbA1c. Methods 137 diabetic patients in our hospital from June 2018 to June 2021 were divided into groups. According to the simple random number table method, the patients were divided into control group (n=68) and observation group (n=69). The control group was treated with metformin hydrochloride and the observation group was treated with Shah Glenn Dean based on the control group. The clinical efficacy, serum insulin (INS), C-peptide, 2-hour postprandial blood glucose (PBG), fasting blood glucose (FBG) and glycosylated hemoglobin of the two groups were evaluated.Results The total effective rate of the observation group was 95.65%, higher than 83.82% of the control group (P<0.05); compared with before treatment, the levels of Ins and C-peptide in the observation group were higher than those in the control group (P<0.05); Compared with before treatment, the levels of PBG, FBG and HbA1c in the observation group were lower than those in the control group.There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion The clinical efficacy of Shah Glenn Dean combined with metformin hydrochloride in the treatment of diabetic patients can improve the levels of Ins and C peptide, reduce the levels of PBG, FBG and HbA1c, and to pancreatic islet β cells play a protective role, patients have less probability of adverse reactions, and the medication is safe and reliable. |
| Key words: Shah Glenn Dean Metformin hydrochloride Diabetes mellitus Islet β cells Target rate |